Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Multicenter Assessment of ALD403 in Frequent Episodic Migraine

ClinicalTrials.gov ID: NCT02559895

Public ClinicalTrials.gov record NCT02559895. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess ALD403 in the prevention of migraine headache in frequent episodic migraineurs.

Study identification

NCT ID
NCT02559895
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alder Biopharmaceuticals, Inc.
Industry
Enrollment
898 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2015 (Type not available)
Primary completion
Feb 2017 (Actual)
Completion
Dec 2017 (Actual)
Last update posted
May 14, 2020

2015 – 2017

United States locations

U.S. sites
83
U.S. states
30
U.S. cities
76
Facility City State ZIP Site status
Research Site Birmingham Alabama 35216 —
Research Site Phoenix Arizona 85013 —
Research Site Tucson Arizona 85712 —
Research Site Little Rock Arkansas 72205 —
Research Site Anaheim California 92801 —
Research Site Fresno California 93702 —
Research Site Fullerton California 92835 —
Research Site Long Beach California 90806 —
Research Site Montclair California 91763 —
Research Site Oceanside California 92056 —
Research Site Redlands California 92374 —
Research Site San Diego California 92103 —
Research Site San Diego California 92108 —
Research Site Santa Monica California 90404 —
Research Site Sherman Oaks California 91403 —
Research Site Colorado Springs Colorado 80918 —
Research Site Fort Collins Colorado 80528 —
Research Site Stamford Connecticut 06905 —
Research Site Waterbury Connecticut 06708 —
Research Site Bradenton Florida 34201 —
Research Site DeLand Florida 32720 —
Research site Fort Myers Florida 33912 —
Research Site Hallandale Florida 33009 —
Research Site Hialeah Florida 33012 —
Research Site Maitland Florida 32751 —
Research Site Miami Florida 33143 —
Research Site Miami Florida 33155 —
Research Site Miami Florida 33173 —
Research Site Naples Florida 34102 —
Research Site Orlando Florida 32801 —
Research Site Sunrise Florida 33351 —
Research Site Winter Haven Florida 33880 —
Research Site Atlanta Georgia 30331 —
Research Site Atlanta Georgia 30342 —
Research Site Stockbridge Georgia 30281 —
Research Site Chicago Illinois 60607 —
Research Site Lisle Illinois 60532 —
Research Site Prairie Village Kansas 66206 —
Research Site Lexington Kentucky 40509 —
Research Site Owensboro Kentucky 42303 —
Research Site New Orleans Louisiana 70115 —
Research Site Boston Massachusetts 02131 —
Research Site North Attleboro Massachusetts 02760 —
Research Site Springfield Massachusetts 01104 —
Research Site Watertown Massachusetts 02472 —
Research Site Ann Arbor Michigan 48104 —
Research Site Farmington Hills Michigan 48334 —
Research Site Jackson Michigan 49201 —
Research Site Minneapolis Minnesota 55402 —
Research Site Flowood Mississippi 39232 —
Research Site Springfield Missouri 65807 —
Research Site St Louis Missouri 63141 —
Research Site Las Vegas Nevada 89119 —
Research Site Reno Nevada 89502 —
Research Site Albuquerque New Mexico 87102 —
Research Site Brooklyn New York 11213 —
Research Site Brooklyn New York 11229 —
Research Site Hartsdale New York 10530 —
Research Site Rochester New York 14609 —
Research Site Staten Island New York 10312 —
Research Site Durham North Carolina 27713 —
Research Site Greensboro North Carolina 27405 —
Research Site High Point North Carolina 27265 —
Research Site Wilmington North Carolina 28401 —
Research Site Dayton Ohio 45424 —
Research Site Edmond Oklahoma 73034 —
Research Site Norman Oklahoma 73069 —
Research Site Oklahoma City Oklahoma 73112 —
Research Site Portland Oregon 97210 —
Research Site Allentown Pennsylvania 18104 —
Research Site Smithfield Pennsylvania 15478 —
Research Site Anderson South Carolina 29621 —
Research Site Chattanooga Tennessee 37404 —
Research Site Chattanooga Tennessee 37421 —
Research Site Kingsport Tennessee 37660 —
Research Site Memphis Tennessee 38119 —
Research Site Austin Texas 78745 —
Research Site Dallas Texas 75231 —
Research Site Houston Texas 77074 —
Research Site Houston Texas 77081 —
Research Site Richmond Virginia 23294 —
Research Site Virginia Beach Virginia 23454 —
Research Site Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02559895, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2020 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02559895 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →